| ZATLOUKAL, Petr, Luboš PETRUŽELKA, Milada ZEMANOVÁ, Vítězslav KOLEK, Jana SKŘIČKOVÁ, Miloš PEŠEK, Hana FOITŮ, Ivona GRYGÁRKOVÁ, Dimka SIXTOVÁ a Jaromír ROUBEC. Gemcitabine plus cisplain vs. gecitabine plus carboplatin in stage IIIb and IV non small cell lung cancer: A phase III randomized trial. Lung Cancer. 2003, roč. 41, č. 3, s. 245-367, 22 s. ISSN 0169-5002. |
Další formáty:
BibTeX
LaTeX
RIS
@article{492259,
author = {Zatloukal, Petr and Petruželka, Luboš and Zemanová, Milada and Kolek, Vítězslav and Skřičková, Jana and Pešek, Miloš and Foitů, Hana and Grygárková, Ivona and Sixtová, Dimka and Roubec, Jaromír},
article_number = {3},
keywords = {non small cell lung cancer; gemcitabine; carboplatin; cisplatin; phase III trial},
language = {eng},
issn = {0169-5002},
journal = {Lung Cancer},
title = {Gemcitabine plus cisplain vs. gecitabine plus carboplatin in stage IIIb and IV non small cell lung cancer: A phase III randomized trial},
volume = {41},
year = {2003}
}
TY - JOUR
ID - 492259
AU - Zatloukal, Petr - Petruželka, Luboš - Zemanová, Milada - Kolek, Vítězslav - Skřičková, Jana - Pešek, Miloš - Foitů, Hana - Grygárková, Ivona - Sixtová, Dimka - Roubec, Jaromír
PY - 2003
TI - Gemcitabine plus cisplain vs. gecitabine plus carboplatin in stage IIIb and IV non small cell lung cancer: A phase III randomized trial
JF - Lung Cancer
VL - 41
IS - 3
SP - 245-367
EP - 245-367
SN - 01695002
KW - non small cell lung cancer
KW - gemcitabine
KW - carboplatin
KW - cisplatin
KW - phase III trial
N2 - The randomized multicenter trial was conducted to compare the tolerability of gemcitabine plus cisplatin GP vs. gemcitabine plus carboplatin GC in chemonaive stage IIIb and IV pts. The enrolled pts, 87 in the GP branch and 89 in GC branch, were balanced demographically and for disease characteristics. Results show that that both regimens were comparable. GC may offer acceptable option for patients unable to receive cisplatin.
ER -
ZATLOUKAL, Petr, Luboš PETRUŽELKA, Milada ZEMANOVÁ, Vítězslav KOLEK, Jana SKŘIČKOVÁ, Miloš PEŠEK, Hana FOITŮ, Ivona GRYGÁRKOVÁ, Dimka SIXTOVÁ a Jaromír ROUBEC. Gemcitabine plus cisplain vs. gecitabine plus carboplatin in stage IIIb and IV non small cell lung cancer: A phase III randomized trial. \textit{Lung Cancer}. 2003, roč.~41, č.~3, s.~245-367, 22 s. ISSN~0169-5002.
|
